Corevitas
Clinical trials sponsored by Corevitas, explained in plain language.
-
Major study launches to track Real-World eczema drug effects in 1500 teens
Knowledge-focused Recruiting nowThis study is creating a large international registry to track the long-term safety and real-world effectiveness of approved eczema medications in teenagers. It will follow about 1500 adolescents, aged 12-15, who have moderate to severe eczema and are starting a new treatment. Th…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Massive 5,000-Person study launches to track hair loss treatments
Knowledge-focused Recruiting nowThis study is collecting information from 5,000 adults with alopecia areata (an autoimmune hair loss condition) who are already being treated by a dermatologist. The goal is to track the long-term safety and effectiveness of real-world treatments over time. Researchers will follo…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC
-
Massive study tracks 1000 lupus patients to find best treatments
Knowledge-focused Recruiting nowThis registry follows 1000 people with lupus during their regular doctor visits to understand how well different treatments work in real life. Researchers collect information about medications, side effects, and how the disease progresses over time. The goal is to help doctors an…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Major teen hair loss study launches to track Real-World treatments
Knowledge-focused Recruiting nowThis study aims to learn about the real-world safety and effectiveness of treatments for severe hair loss (alopecia areata) in teenagers. It will follow 1,500 adolescents aged 12-17 who are receiving standard care from their dermatologists. Researchers will collect information on…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Major study launches to track rare skin disease patterns
Knowledge-focused Recruiting nowThis study is collecting information from about 200 adults with generalized pustular psoriasis (GPP) to better understand how this rare skin condition progresses over time and how treatments work in real-world settings. Researchers will track what medications patients use, how th…
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC